Medical Net, Inc.
3645.T · JPX
11/30/2025 | 8/31/2025 | 5/31/2025 | 2/28/2025 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.05 | -0.47 | -0.06 | 0.01 |
| FCF Yield | 0.00% | 0.00% | 0.00% | 0.00% |
| EV / EBITDA | 16.25 | 34.97 | -10.27 | -32.54 |
| Quality | ||||
| ROIC | 1.40% | 0.49% | 1.26% | 0.40% |
| Gross Margin | 28.27% | 32.45% | 30.16% | 31.46% |
| Cash Conversion Ratio | – | – | – | – |
| Growth | ||||
| Revenue 3-Year CAGR | 10.26% | 10.70% | 10.52% | 24.40% |
| Free Cash Flow Growth | 0.00% | 0.00% | 0.00% | 0.00% |
| Safety | ||||
| Net Debt / EBITDA | -4.31 | -4.35 | 0.80 | 0.62 |
| Interest Coverage | 19.47 | 7.40 | 14.77 | 4.14 |
| Efficiency | ||||
| Inventory Turnover | 4.76 | 2.66 | 3.63 | 3.56 |
| Cash Conversion Cycle | 33.86 | 42.27 | 40.99 | 42.87 |